Economy

Exact Sciences Corporation (EXAS) Sets New 52-Week High Following Earnings Beat

Exact Sciences Corporation (NASDAQ:EXAS) reported its EPS in the last quarter as $-0.23/Share beating the analyst estimate of $-0.3/Share by a difference of $0.07. In a research report issued to clients and investors on 31 October, EXACT Sciences (NDAQ:EXAS) shares have had their "Buy" Rating restate by research analysts at Benchmark.

Hedge funds have recently modified their holdings of the stock. Ameritas Investment Partners Inc. increased its position in shares of Exact Sciences Corporation by 5.6% in the second quarter. EXACT Sciences Corporation (NASDAQ:EXAS) has risen 458.24% since November 1, 2016 and is uptrending. Federated Investors Inc. PA now owns 34,553 shares of the medical research company's stock worth $1,222,000 after buying an additional 12,018 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Exact Sciences Corporation by 17.3% in the second quarter. Prudential Financial Inc. now owns 11,141 shares of the medical research company's stock worth $263,000 after acquiring an additional 320 shares in the last quarter. For the week, the stock is performing 1.97%.

Exact Sciences Corporation (NASDAQ:EXAS) belongs to Healthcare sector, the firm standing on a contradictory position. The stock was sold at an average price of $47.16, for a total transaction of $1,373,063.40. Following the completion of the purchase, the director now owns 60,858 shares in the company, valued at $2,294,955.18. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The stock was sold at an average price of $40.81, for a total value of $3,088,623.23. Following the sale, the insider now owns 308,377 shares in the company, valued at $12,584,865.37. The disclosure for this purchase can be found here.

The company now has an insider ownership of 2.1 Percent and Institutional ownership of 87.4 Percent. Corporate insiders own 4.00% of the company's stock. Qs Investors Ltd Limited Liability Company has 0% invested in EXACT Sciences Corporation (NASDAQ:EXAS) for 2,518 shares. According to today's trading volume Exact Sciences Corporation is ABOVE its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days. Exact Sciences Corporation has a 1-year low of $13.05 and a 1-year high of $57.95. The Firm has ATR of 1.99 that is explaining range of a day's trading is high-low; ATR expands it to yesterday's closing price if it was outside of current range.

Exact Sciences Corporation (NASDAQ:EXAS) last posted its quarterly earnings data on Monday, October 30th. The stock of EXACT Sciences Corporation (NASDAQ:EXAS) earned "Buy" rating by TH Capital on Wednesday, February 22. The company had revenue of $72.60 million for the quarter, compared to analyst estimates of $65.03 million.

Analysts have a mean recommendation of 2.30 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range).

09/21/2017 - EXACT Sciences Corporation had its "outperform" rating reiterated by analysts at Leerink Swann. Finally, Canaccord Genuity upgraded Exact Sciences Corporation to a "buy" rating and set a $60.00 target price on the stock in a research report on Tuesday. Craig Hallum increased their target price on Exact Sciences Corporation from $46.00 to $61.00 and gave the stock a "buy" rating in a research report on Tuesday. Five research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of "Buy" and an average price target of $49.71.

COPYRIGHT VIOLATION WARNING: "Horseman Capital Management Ltd Takes Position in Exact Sciences Corporation (EXAS)" was originally reported by Week Herald and is the property of of Week Herald. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States & global trademark and copyright legislation. The correct version of this piece can be read at https://stocknewstimes.com/2017/11/01/exact-sciences-corporation-exas-sets-new-52-week-high-following-earnings-beat.html.

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. The Firm focuses on the early detection and prevention of some forms of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population.



Like this

Latest


01 November 2017
SodaStream International Ltd. (SODA) Issues FY17 Earnings Guidance
Eqis Capital Management Inc. increased its stake in shares of SodaStream International by 0.6% in the third quarter. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the company.

01 November 2017
Canaccord Genuity Raises Franco Nevada Corp (FNV) Price Target to C$119.00
It is highly important for investors to understand exactly what risks they are taking when buying and selling stocks. The value of the investment in FNV increased from $1,467,000 to $1,530,000 a change of $63,000 quarter over quarter.

01 November 2017
Government to introduce laws to encourage use of drones
We have studied various policies from all across the globe and formulated a drone policy which would encourage this industry. Besides "RFID/SIM", drones should have return to home option and anti-collision lights, as per the draft rules.

01 November 2017
The Navios Maritime Partners LP (NMM) Scheduled to Post Earnings on Monday
The stock of Navios Maritime Partners L.P. (NYSE:NMM) has "Underweight" rating given on Thursday, October 15 by JP Morgan. Navios Maritime Midstream Partners LP was downgraded to "underperform" by analysts at Bank of America Merrill Lynch.

01 November 2017
The Brinker Capital Inc. Buys 13402 Shares of H&R Block Inc. (HRB)
H&R Block, Inc. (HRB ) shares are down -3.62% for the week and that has got investors and traders sitting up and taking note. Note, this compares with a consensus analyst forecast of -0.73 in earnings per share for its next fiscal quarterly report.

01 November 2017
Demi Lovato's Halloween Costume Will Have You Wanting To Get Arrested
Complementing her sassy Halloween look, the 25-year-old accessorised with a police cap, black stockings and some dark manicure. Kim and Jonathan, 43, wore costumes inspired by what the iconic singing duo wore to the Academy Awards in 1973.

01 November 2017
Dextrin Market by Top Manufacturers 2017 Cargill, Emsland Group, Vijaya Lakshmi Adhesives
The report highlights exhaustive study of major market and their present trends, along with corresponding market segments. Geographically , the market has been analyzed across North America, Europe, China, Japan, Southeast Asia, and India.

01 November 2017
The nightmare of a 7-year-old at the airport of Geneva
A seven-year-old girl boarded a plane on her own after breezing through security without a ticket at Geneva Airport. The spokesman also said that steps are being taken to ensure that such an incident does not occur again.

01 November 2017
OH attorney general calls for opiate manufacturers to pay
DeWine's new recovery plan includes - among other things - more treatment options and an expansion in prevention programs. Unlike Cuyahoga County and other local governments, OH is not suing any wholesale drug distributors.

01 November 2017
Analyst Earnings Estimates Scan: Harley-Davidson, Inc. (HOG)
When a stock traded on high volume then is it is good time for active Investors to attain the opportunity of this situation. Harley-Davidson, Inc. on 9/29/2017 reported its EPS as $0.27 with the analysts projecting the EPS of the stock as $0.31.



Recommended